569 related articles for article (PubMed ID: 15111319)
1. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
[TBL] [Abstract][Full Text] [Related]
2. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G
Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378
[TBL] [Abstract][Full Text] [Related]
3. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.
Ryo A; Liou YC; Wulf G; Nakamura M; Lee SW; Lu KP
Mol Cell Biol; 2002 Aug; 22(15):5281-95. PubMed ID: 12101225
[TBL] [Abstract][Full Text] [Related]
4. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
Suizu F; Ryo A; Wulf G; Lim J; Lu KP
Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
[TBL] [Abstract][Full Text] [Related]
5. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
6. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.
Zhou XZ; Kops O; Werner A; Lu PJ; Shen M; Stoller G; Küllertz G; Stark M; Fischer G; Lu KP
Mol Cell; 2000 Oct; 6(4):873-83. PubMed ID: 11090625
[TBL] [Abstract][Full Text] [Related]
7. Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma.
Leung KW; Tsai CH; Hsiao M; Tseng CJ; Ger LP; Lee KH; Lu PJ
Oncol Rep; 2009 Apr; 21(4):1097-104. PubMed ID: 19288014
[TBL] [Abstract][Full Text] [Related]
8. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
[TBL] [Abstract][Full Text] [Related]
9. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
10. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
[TBL] [Abstract][Full Text] [Related]
11. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells.
Zhou L; Park BH; Park JH; Jang KY; Park HS; Wagle S; Lee KB; Kim JR
Oncol Rep; 2013 Jan; 29(1):193-8. PubMed ID: 23129219
[TBL] [Abstract][Full Text] [Related]
13. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
14. Pinning down proline-directed phosphorylation signaling.
Lu KP; Liou YC; Zhou XZ
Trends Cell Biol; 2002 Apr; 12(4):164-72. PubMed ID: 11978535
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
Zhou XZ; Lu PJ; Wulf G; Lu KP
Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation-specific prolyl isomerization: is there an underlying theme?
Wulf G; Finn G; Suizu F; Lu KP
Nat Cell Biol; 2005 May; 7(5):435-41. PubMed ID: 15867923
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
Kim G; Kim JY; Choi HS
Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
20. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
